FMS Cache Rx Products
The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) is seeking to procure a comprehensive range of FDA-approved pharmaceuticals for the Strategic National Stockpile (SNS), a critical national repository of medical supplies used during public health emergencies. The solicitation (75A50325Q00006) requires delivery of 224 different pharmaceutical products, ranging from common medications like acetaminophen to specialized medical supplies, with contractors responsible for providing brand name or equal products. The government will evaluate proposals based on technical capabilities, past performance, and price, with technical factors being more important than pricing considerations. Potential bidders must complete detailed technical and business volumes, including a technical product list, pricing template, and representations and certifications. Key deadlines include February 21, 2025, for submitting questions and March 7, 2025, at 11:00 a.m. Eastern Time for proposal submission.
The solicitation is a full and open competition with no specific set-aside designations, classified under NAICS code 325412 for Pharmaceutical Preparation Manufacturing with a size standard of 1,300 employees. Large business offerors are required to submit small business subcontracting plans, demonstrating commitment to supporting smaller enterprises. The contract structure includes a 12-month base ordering period with four additional 12-month optional ordering periods, allowing for potential five-year engagement. Contractors must meet rigorous requirements, including maintaining a minimum 80% shelf life upon delivery, complying with the Buy American Act, and possessing proper DEA licensing for controlled substances. The place of performance is located in Chamblee, GA 30341, and the government intends to award one or more firm-fixed-price contracts to qualified vendors capable of meeting the Strategic National Stockpile's critical pharmaceutical inventory needs.
75A50325Q00006 Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response
2/14/25, 11:58 AM 6505--766-25-1-400-0289 -Charleston CMOP CLOMIPHENE CITRATE -(VA-25-00034392)
The Department of Veterans Affairs Veterans Health Administration (VA) is seeking quotes for Clomiphene Citrate 50mg tablets through solicitation 36C77025Q0121. The procurement is specifically for the Charleston Consolidated Mail Outpatient Pharmacy (CMOP) facility, with a requirement to purchase 720 bottles of 30-count tablets. Vendors must meet several critical qualifications, including possessing a valid state wholesale distributor license and providing pharmaceuticals with at least one year until expiration. The solicitation requires vendors to submit a signed SF1449 form, completed pricing spreadsheet, and a Buy American Act certificate. Quotes are due by February 20, 2025, at 3:00 PM Central Time, with vendors limited to submitting only one quote via email to Jennifer.Coleman4@va.gov.
The solicitation is classified under NAICS category 325412 for Pharmaceutical Preparation Manufacturing, with a small business size standard of 1,300 employees. While no specific set-aside was indicated in the initial documents, the RFQ notes it is a total small business opportunity. The pharmaceutical products must be shippable by USPS and include bar code labeling conforming to GS1-128 or HIBCC standards. Delivery is required within 10 days after receipt of order to the Charleston CMOP facility located at 4136 Carolina Commerce Parkway in Ladson, SC 29456. The procurement seeks to acquire pharmaceutical products with stringent quality and delivery specifications, emphasizing the VA's commitment to maintaining a reliable pharmaceutical supply chain for veteran healthcare services.
36C77025Q0121 Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15
2/13/25, 11:55 AM 6505--Bevacizumab Injection
The Department of Veterans Affairs National Acquisition Center is soliciting offers for Bevacizumab injection pharmaceutical products to be supplied through pharmaceutical prime vendors (PPVs) to VA facilities, Department of Defense, Indian Health Service, and Bureau of Prisons. The solicitation seeks multiple strengths of Bevacizumab (25mg/mL in 4mL and 16mL vials), including brand names such as Avastin, Mvasi, Alymsys, Vegzelma, and Zirabev. The contract will be awarded as a firm-fixed price requirements contract with a one-year base period and four one-year option periods. Evaluation will be conducted using a lowest price technically acceptable (LPTA) methodology, with offerors required to meet all technical specifications and FDA cGMP compliance standards. Proposals are due on March 6, 2025, at 2:30 PM CT, with a mandatory 60-day implementation period for establishing distribution agreements with prime vendors.
The solicitation is unrestricted, meaning all businesses can compete, though large businesses must submit a subcontracting plan for contracts exceeding $750,000. Estimated annual quantities include 23,448 vials for the 4mL size and 13,841 vials for the 16mL size. Contractors must distribute products through McKesson Corporation (VA PPV) and specified DoD PPV contractors, and include a 0.5% Cost Recovery Fee in their pricing. Offerors must provide unique 11-digit NDC numbers specific to their company. The contract will leverage the Pharmaceutical Preparation Manufacturing NAICS code (325412) and the Drugs and Biologicals PSC category (6505). While no specific incumbent is mentioned, the solicitation indicates a structured approach to pharmaceutical product procurement across multiple federal healthcare systems.
36E79725R0019 Department of Veterans Affairs National Acquisition Center
2/20/25, 4:42 PM 6505--Domestic Pharmaceuticals/Med/Surge
The Department of Veterans Affairs (VA) Veterans Health Administration is conducting market research to identify domestic pharmaceutical manufacturers capable of supplying 49 different pharmaceutical products for the Consolidated Mail Outpatient Pharmacy (CMOP) program. The pharmaceuticals range from glucose test strips and hypertension medications to treatments for HIV, osteoporosis, and various other medical conditions. Potential contractors must manufacture these products domestically for an estimated seven VA facilities, providing all necessary labor, materials, quality assurance, and delivery while complying with federal, state, and local regulations. Interested manufacturers are required to submit a comprehensive capability statement by February 5, 2025, at 16:30 CDT to Josie Linaweaver, detailing company information, socioeconomic categories, manufacturing capabilities, distributor networks, and pricing details. The solicitation uses NAICS codes 325412 and 325413, with a business size standard of 1,250 employees, and requires potential contractors to be registered in the System for Award Management (SAM) database.
This pre-solicitation notice is not a formal solicitation and does not guarantee a contract award, but serves as a market research tool to assess industry capabilities. There are no specific set-aside designations for this opportunity, meaning both small and large businesses can participate. The document does not specify a precise award value or budget range, but the breadth of pharmaceutical products suggests a potentially significant contract. Manufacturers must provide information on their ability to consistently supply medications, including average prescription costs, stock availability history, and any existing GSA/FSS/NAC schedule contract numbers. The VA is particularly interested in understanding the domestic manufacturing capacity for these specific pharmaceuticals, with a focus on reliability, quality, and regulatory compliance. Potential contractors are advised that this request for information is solely for planning purposes and that responding does not constitute an offer or guarantee of future contract opportunities.
36C77025Q0124 Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15
1/21/25, 2:25 PM 6505--Diclofenac Sodium (NA) 1% Gel
The Department of Veterans Affairs National Acquisition Center is seeking a contractor to supply Diclofenac Sodium 1% Gel in 100-gram tubes through an unrestricted competitive solicitation. The procurement will serve VA facilities, DoD Pharmaceutical Prime Vendors, Indian Health Service facilities, Bureau of Prisons facilities, Federal Health Care Center, and State Veteran Homes. Offerors must provide their unique 11-digit NDC or UPC number, comply with Drug Supply Chain Security Act requirements, and establish business distribution agreements with VA and DoD Pharmaceutical Prime Vendors within 60 days of contract award. The solicitation requires contractors to submit one sample boxed tube by March 4, 2025, at 2:30 PM Central Time and includes specific requirements for bar coding, FDA facility compliance, and quarterly sales reporting. A HUBZone price evaluation preference will be applied during the competitive assessment, and pricing must incorporate a 0.5% Cost Recovery Fee with amounts limited to two decimal places.
The contract includes an estimated annual quantity of 4,749,159 tubes for the base year with four additional one-year option periods. Products must be manufactured in FDA-compliant facilities and maintain acceptable current Good Manufacturing Practice (cGMP) status throughout the contract period. While no specific set-aside is designated, the solicitation is an unrestricted competition that allows for broad participation across pharmaceutical manufacturers. The procurement falls under NAICS Category 325412 for Pharmaceutical Preparation Manufacturing and PSC Category 6505 for Drugs and Biologicals. Contractors will need to demonstrate robust quality control processes, regulatory compliance, and the capability to consistently supply large volumes of the specified medication to multiple federal healthcare systems. The contract will likely involve significant distribution logistics and ongoing quality assurance to meet the comprehensive requirements of multiple federal healthcare organizations.
36E79725R0012 Department of Veterans Affairs National Acquisition Center
2/10/25, 4:31 PM